Discovering, developing, and manufacturing next generation live biotherapeutics

Our state-of-the-art plat­form enables an unprece­dent­ed under­stand­ing of host-micro­bio­me inter­ac­tion and pro­vides an effi­cient approach to drug discovery.

Platform graphic featuring the for pieces of the Kanvas platform: Characterization, Selection, Manufacturing, and Translation. They all point toward the center goal text: "Next Generation Live Biotherapeutics"
  • Mechanism

    Visualization of host-microbiome interaction in situ

  • Manufacturing

    Reproducible large-scale manufacturing of complex consortia

  • Complexity

    Formulating live biotherapeutics that optimize healthy human-gut microbiome

A novel approach, from microbiome profiling to high-throughput drug manufacturing.

A plat­form for dis­cov­er­ing, devel­op­ing, and man­u­fac­tur­ing next-gen­er­a­tion live bio­ther­a­peu­tics takes advan­tage of our foun­da­tion­al under­stand­ing of the micro­bio­me, address­ing all FDA require­ments and accel­er­at­ing crit­i­cal steps along the drug devel­op­ment pathway.

HiPR-FISH Tech­nol­o­gy

Mapping host-microbiome interactions in situ at high resolution & multiplexity

We simul­ta­ne­ous­ly iden­ti­fy host-cell tran­scripts and micro­bial tax­on­o­my. By pro­fil­ing host-micro­bio­me inter­ac­tion in situ, we can gain an unprece­dent­ed under­stand­ing of the micro­bio­me for nov­el ther­a­peu­tic development.

A mixture of highlighted microbes interacting, differentiated by their bright pink and green colors
Kanvas Biosciences’ imaging platform is capable of rapid microbial identification and characterization in complex communities.

ACT™ Man­u­fac­tur­ing: Anaer­o­bic Co-cul­ture Technology

Manufacturing consortia from purified cell lines

We co-cul­ture com­mu­ni­ties of iso­lat­ed strains at an indus­tri­al scale with our state-of-the-art pro­duc­tion technology.

A scientist working in the lab at Kanvas Bio headquarters

Plat­form Partnerships

We work with partners to better understand the microbiome and its role in disease and drug candidates.

We have a vast part­ner­ship net­work made up of some of the top biotech­nol­o­gy and phar­ma­ceu­ti­cal com­pa­nies in the sci­en­tif­ic community.

Our pipeline enables rapid screen­ing of sev­er­al drug can­di­dates for dif­fer­ent dis­eases to ben­e­fit patients as soon as possible.